[opensourcepharma] Although the policy speaks of encouraging open source drug discovery (OSDD), it is well known that the OSDD programme is no longer being pursued by CSIR. - See more at: http://www.epw.in/journal/2016/24/commentary/wrong-incentive.html#sthash.krH3nH5S.dpuf

• Next message: [opensourcepharma] food for thought - NY Times op-ed on patents/generics/innovation:
• Messages sorted by: [ date ] [ thread ] [ subject ] [ author ]

http://www.epw.in/journal/2016/24/commentary/wrong-incentive.html
-- 
 JALEEL
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.okfn.org/pipermail/opensourcepharma/attachments/20160613/ca66a14d/attachment.html>

• Next message: [opensourcepharma] food for thought - NY Times op-ed on patents/generics/innovation:
• Messages sorted by: [ date ] [ thread ] [ subject ] [ author ]